• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association.

出版信息

Acta Ophthalmol Scand Suppl. 2000(232):49-50. doi: 10.1111/j.1600-0420.2000.tb01102.x.

DOI:10.1111/j.1600-0420.2000.tb01102.x
PMID:11235535
Abstract
摘要

相似文献

1
Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association.原发性开角型青光眼和高眼压症的降压疗效：拉坦前列素单药治疗与噻吗洛尔和多佐胺联合治疗的对比
Acta Ophthalmol Scand Suppl. 2000(232):49-50. doi: 10.1111/j.1600-0420.2000.tb01102.x.
2
Latanoprost versus combined timolol and dorzolamide.拉坦前列素与噻吗洛尔和多佐胺联合用药的对比
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S148-54. doi: 10.1016/s0039-6257(02)00290-4.
3
Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.拉坦前列素与多佐胺在噻吗洛尔基础上加用治疗开角型青光眼或高眼压症患者时的附加降眼压效果比较：希腊一项随机、开放标签、多中心研究
J Glaucoma. 2001 Aug;10(4):316-24. doi: 10.1097/00061198-200108000-00012.
4
Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.拉坦前列素单药治疗与在噻吗洛尔中添加多佐胺治疗青光眼和高眼压症患者的疗效及副作用——一项为期三个月的随机研究。西班牙拉坦前列素研究组
Eur J Ophthalmol. 2000 Jul-Sep;10(3):198-204.
5
Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study.拉坦前列素单药治疗与多佐胺联合噻吗洛尔治疗青光眼和高眼压症患者的比较：一项为期3个月的随机研究。
Graefes Arch Clin Exp Ophthalmol. 2000 Jan;238(1):19-23. doi: 10.1007/s004170050003.
6
Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.拉坦前列素与噻吗洛尔联合多佐胺治疗：开角型青光眼的降眼压效果
Acta Ophthalmol Scand. 2001 Feb;79(1):6-9. doi: 10.1034/j.1600-0420.2001.079001006.x.
7
Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.拉坦前列素与固定复方制剂多佐胺和噻吗洛尔治疗成年高眼压患者的比较：一项在拉丁美洲进行的为期八周的随机、开放标签、平行组、多中心研究。
Clin Ther. 2004 May;26(5):755-68. doi: 10.1016/s0149-2918(04)90075-6.
8
Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.在原发性开角型青光眼或高眼压症患者中，将0.005%拉坦前列素与0.2%溴莫尼定或2%多佐胺添加到局部β-肾上腺素能阻滞剂中时的疗效和安全性比较。
J Ocul Pharmacol Ther. 2000 Jun;16(3):251-9. doi: 10.1089/jop.2000.16.251.
9
Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension.固定联合制剂拉坦前列素/噻吗洛尔和多佐胺/噻吗洛尔治疗开角型青光眼或高眼压症的疗效和安全性。
Eye (Lond). 2010 Jul;24(7):1234-42. doi: 10.1038/eye.2009.307. Epub 2009 Dec 18.
10
Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension.拉坦前列素、溴莫尼定以及噻吗洛尔与多佐胺固定复方制剂对原发性开角型青光眼和高眼压症患者昼夜眼压的比较。
Acta Ophthalmol Scand Suppl. 2002;236:55. doi: 10.1034/j.1600-0420.80.s236.34.x.

引用本文的文献

1
Pharmacological management of primary open-angle glaucoma: second-line options and beyond.原发性开角型青光眼的药物治疗：二线及其他治疗选择
Drugs Aging. 2008;25(9):729-59. doi: 10.2165/00002512-200825090-00002.
2
Latanoprost : an update of its use in glaucoma and ocular hypertension.拉坦前列素：其在青光眼和高眼压症治疗中的应用进展
Drugs Aging. 2003;20(8):597-630. doi: 10.2165/00002512-200320080-00005.